Skip to main content
. 2013 Dec;11(4):210–218. doi: 10.3121/cmr.2013.1156

Table 3.

Comparisons between history of prostate cancer and patient characteristics.

Variables Na Cancer History (Males Only) P value
Prostate Cancer (N = 81)
n (%) or median (IQR)
None (N = 1838)
n (%) or median (IQR)
Age (years) 1919 <0.001
 18–44 0 (0) 90 (4.9)
 45–59 7 (8.6) 566 (30.8)
 60–74 39 (48.1) 951 (51.7)
 75+ 35 (43.2) 231 (12.6)
Age (years, continuous) 1919 73 (66 – 79) 63 (56 – 70) <0.001
Age at diabetes diagnosis 1883 64.5 (54 – 71.8) 55 (48 – 63) <0.001
High co-morbidity (2+) 1919 46 (56.8) 407 (22.1) <0.001
Comorbidities
 Chronic obstructive pulmonary disease 1919 7 (8.6) 108 (5.9) 0.305
 Kidney disease 1919 5 (6.2) 97 (5.3) 0.725
 Heart disease 1919 32 (39.5) 479 (26.1) 0.007
 Stroke 1919 10 (12.3) 130 (7.1) 0.074
 Arthritis 1919 27 (333) 463 (25.2) 0.100
 High blood pressure 1919 39 (48.1) 770 (41.9) 0.265
 Osteoporosis 1919 6 (7.4) 38 (2.1) 0.002
Number of diabetic complications 1879 1 (0 – 3) 1 (0 – 2) 0.145
Duration of diabetes 1919 7 (4 – 9) 6 (3 – 9) 0.137
Metformin use (yes) 1919 38 (46.9) 1067 (58.0) 0.047
HbA1c result scoreb 1588 2 (1 – 3) 2 (1 – 3) 0.678
Obesity (BMI > 30) 1780 31 (42.5) 802 (47.0) 0.449
Risky/high drinker alcohol use 1901 5 (6.2) 158 (8.7) 0.448
Have you ever smoked (yes) 1731 45 (60.0) 1074 (64.8) 0.390
General Quality of Life Surveyc
 Problems with mobility 1893 41 (51.2) 526 (29.0) <0.001
 Problems with self-care 1889 6 (7.5) 135 (7.5) 0.990
 Problems with usual activities 1898 28 (35.0) 447 (24.6) 0.035
 Problems with pain 1886 45 (57.0) 938 (51.9) 0.379
 Problems with anxiety 1879 22 (27.8) 556 (30.9) 0.567
Diabetes-dependent Quality of Life 1827 −0.94 (−2.0 – −0.26) −1.15 (−2.5 – −0.39) 0.057

BMI, body mass index; HbA1c, hemoglobin A1c

a

Data was not available for all patients for all variables

b

1 ≤ 6.5%; 2 = 6.5–7%; 3 = 7.1–8%; 4 ≥ 8%

c

Five domains of the European Quality of Life Survey